Patent · US Active

Substituted triazolopyridines

US9555022B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Volker Schulze · Hohen Neuendorf, DE
Dirk Kosemund · Berlin, DE
Hartmut Schirok · Wuppertal, DE
Benjamin Bader · Berlin, DE
Philip Lienau · Berlin, DE
Antje Margret Wengner · Berlin, DE
Hans Briem · Bremen, DE
Simon Holton · Berlin, DE
Gerhard Siemeister · Berlin, DE
Stefan Prechtl · Berlin, DE
Marcus Koppitz · Berlin, DE
Detlef STÖCKIGT · Potsdam, DE
Olaf Prien · Berlin, DE

Key dates

Filing date	Jun 14, 2011
Grant date	Jan 31, 2017
Priority date	—
Expiry date	Feb 6, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted triazolopyridine compounds of general formula (I): in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease of uncontrolled cell growth, proliferation and/or survival as well as to the use of intermediate compounds for the preparation of said compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.